echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > GUT: IBD patients treated with infliximab will have a weakened anti-coronavirus antibody response

    GUT: IBD patients treated with infliximab will have a weakened anti-coronavirus antibody response

    • Last Update: 2021-03-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    The induction of protective immunity after SARS-CoV-2 infection and/or vaccination is essential to suppress transmission.


    The induction of protective immunity after SARS-CoV-2 infection and/or vaccination is essential to suppress transmission.


     

     

     

    The researchers compared IBD patients treated with infliximab with patients treated with vedolizumab, and explored the relationship between patients' reduced response to vaccines or increased sensitivity to systemic infections.


     

     

     

    Patients using two different biological agents had similar symptoms and confirmed SARS-CoV-2 infection rates between the two groups.


     

     

     

    Therefore, this study finally confirmed that infliximab is related to the weakened serological response to the new coronavirus (SARS-CoV-2), and immunomodulators as concomitant therapy further weakened this response.


    Therefore, this study finally confirmed that infliximab is related to the weakened serological response to the new coronavirus (SARS-CoV-2), and immunomodulators as concomitant therapy further weakened this response.


     

     

    Original source:

    Nicholas A Kennedy.


    bmj.
    com/content/early/2021/03/19/gutjnl-2021-324388" target="_blank" rel="noopener">Anti-SARS-CoV-2 antibody responses are attenuated in patients with IBD treated with infliximab.
    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.